Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

被引：0
作者：
Antoinette MaassenVanDenBrink
Gisela M. Terwindt
Arn M. J. M. van den Maagdenberg
机构：
[1] Erasmus MC,Department of Internal Medicine, Division of Vascular Medicine and Pharmacology
[2] Leiden University Medical Centre,Department of Neurology
[3] Leiden University Medical Centre,Department of Human Genetics
来源：
Genome Medicine | / 10卷
关键词：
Calcitonin Gene-related Peptide (CGRP); Chronic Migraine; Erenumab; Fremanezumab; Receptor Activity-modifying Proteins (RAMP1);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
引用
收藏
相关论文
共 47 条
  • [1] Goadsby PJ(2017)Pathophysiology of migraine: a disorder of sensory processing Physiol Rev 97 553-622
  • [2] Holland PR(2015)Migraine pathophysiology: lessons from mouse models and human genetics Lancet Neurol 14 65-80
  • [3] Martins-Oliveira M(2017)The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine Headache 57 47-55
  • [4] Hoffmann J(2017)Blocking CGRP in migraine patients—a review of pros and cons J Head Pain 18 96-2132
  • [5] Schankin C(2017)A controlled trial of erenumab for episodic migraine N Engl J Med 377 2123-2122
  • [6] Akerman S(2017)Fremanezumab for the preventive treatment of chronic migraine N Engl J Med 377 2113-788
  • [7] Ferrari MD(2016)Wiping out CGRP: potential cardiovascular risks Trends Pharmacol Sci 37 779-1062
  • [8] Klever RR(2014)An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress Hypertension 63 1056-414
  • [9] Terwindt GM(2015)CGRP as a neuropeptide in migraine: lessons from mice Br J Clin Pharmacol 80 403-3665
  • [10] Ayata C(2017)Migraine, neurogenic inflammation, drug development—pharmacochemical aspects Curr Med Chem 24 3649-undefined
12345